Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Cancer Research

• Publication date

  2016-07-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-16-0511PMID 27401251PMCID PMC5161709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pancreatic cancer

  2016cited by this paper
• Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• Which patients with resectable pancreatic cancer truly benefit from oncological resection: is it destiny or biology?

  2015cited by this paper
• A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma

  2014cited by this paper
• Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

  2014cited by this paper
• Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer

  2013cited by this paper
• Pancreatic cancer.

  2013cited by this paper
• Abstract 4472: Circulating thyroxine (T4), thyroid-stimulating hormone (TSH), and hypothyroid status and the risk of prostate cancer

  2012cited by this paper
• Pancreatic ductal adenocarcinoma: long-term survival does not equal cure.

  2012cited by this paper
• Targeting eNOS in pancreatic cancer.

  2012cited by this paper
• Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer.

  2012cited by this paper
• Pancreatic cancer

  2011cited by this paper
• eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity.

  2011cited by this paper
• Platelet-Endothelial Cell Adhesion Molecule-1 Regulates Endothelial NO Synthase Activity and Localization Through Signal Transducers and Activators of Transcription 3–Dependent NOSTRIN Expression

  2011cited by this paper
• Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy

  2011cited by this paper
• Inflammation and oncogenesis: a vicious connection.

  2010cited by this paper
• Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

  2010cited by this paper
• Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

  2010cited by this paper
• Nitric oxide and pancreatic cancer pathogenesis, prevention, and treatment.

  2010cited by this paper
• eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues.

  2009cited by this paper
• FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.

  2009cited by this paper
• Pancreatic Adenocarcinoma: The Actual 5-Year Survivors

  2008cited by this paper
• Tumour maintenance is mediated by eNOS

  2008cited by this paper
• Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia.

  2008cited by this paper
• MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

  2007cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• Subcellular targeting and trafficking of nitric oxide synthases.

  2006cited by this paper
• Expression of endothelial nitric oxide synthase correlates with the angiogenic phenotype of and predicts poor prognosis in human gastric cancer

  2005cited by this paper
• ONCOMINE: a cancer microarray database and integrated data-mining platform.

  2004cited by this paper
• Radical causes of cancer

  2003cited by this paper
• NOSTRIN: A protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase

  2002cited by this paper
• NOSIP, a novel modulator of endothelial nitric oxide synthase activity

  2001cited by this paper
• Nitric oxide synthases: structure, function and inhibition.

  2001cited by this paper
• Association of increased immunostaining for inducible nitric oxide synthase and nitrotyrosine with fibroblast growth factor transformation in pancreatic cancer.

  1999cited by this paper
• The role of nitric oxide (NO.) in the carcinogenic process.

  1996cited by this paper
• Nitric oxide production in relation to spontaneous B-cell lymphoma and myositis in SJL mice.

  1995cited by this paper
• Cancer statistics

  1989cited by this paper

• Single-cell and multi-omics analysis identifies TRIM9 as a key ubiquitination regulator in pancreatic cancer

  2025cites this paper
• Identification of a fibroblast-derived gene signature reveals prognostic and therapeutic insights in pancreatic cancer

  2025cites this paper
• Nitric oxide-mediated S-Nitrosylation contributes to signaling transduction in human physiological and pathological status (Review)

  2025cites this paper
• Multi-omics integration and machine learning uncover molecular basal-like subtype of pancreatic cancer and implicate A2ML1 in promoting tumor epithelial-mesenchymal transition

  2025cites this paper
• The impact of endothelin-1 on the efficacy of anti-VEGF therapy: A rationale for dual antagonism

  2025cites this paper
• Imaging Techniques and Biochemical Biomarkers: New Insights into Diagnosis of Pancreatic Cancer

  2024cites this paper
• Immune-related signature identifies IL1R2 as an immunological and prognostic biomarker in pancreatic cancer

  2024cites this paper
• Reprogramming of urea cycle in cancer: Mechanism, regulation and prospective therapeutic scopes.

  2024cites this paper
• REDONE-PD: Reflections of Dopamine-Related Gene Mutations on Neurocognitive Functions in Healthy Controls and Parkinson’s Disease

  2024cites this paper
• Construction of a prognostic model with exosome biogenesis- and release-related genes and identification of RAB27B in immune infiltration of pancreatic cancer

  2024cites this paper
• NOSTRIN is involved in benign prostatic hyperplasia via inhibition of proliferation, oxidative stress, and inflammation in prostate epithelial cells

  2024cites this paper
• Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas

  2024cites this paper
• Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy

  2022cites this paper
• Gene Expression Characteristics of Tumor and Adjacent Non-Tumor Tissues of Pancreatic Ductal Adenocarcinoma (PDAC) In-Silico

  2022influential citation
• PCDH1 promotes progression of pancreatic ductal adenocarcinoma via activation of NF-κB signalling by interacting with KPNB1

  2022cites this paper
• Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)

  2022cites this paper
• Clustering analysis revealed the autophagy classification and potential autophagy regulators' sensitivity of pancreatic cancer based on multi‐omics data

  2022cites this paper
• Identification of Prognosis-Related Molecular Subgroups and Construction of a Prognostic Prediction Model Using Immune-Related Genes in Pancreatic Cancer

  2022influential citation
• Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression

  2022cites this paper
• Development of a Gene Risk Signature for Patients of Pancreatic Cancer

  2022cites this paper
• Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways

  2021cites this paper
• Comparative Gene Signature of (−)-Oleocanthal Formulation Treatments in Heterogeneous Triple Negative Breast Tumor Models: Oncological Therapeutic Target Insights

  2021cites this paper
• S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer

  2021cites this paper
• Tabula Microcebus: A transcriptomic cell atlas of mouse lemur, an emerging primate model organism

  2021cites this paper
• Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation

  2020cites this paper
• Prognostic value of microRNAs in pancreatic cancer: a meta-analysis

  2020influential citation
• Arginine metabolism: a potential target in pancreatic cancer therapy

  2020cites this paper
• Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies

  2020cites this paper
• ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer

  2019cites this paper
• Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis

  2019cites this paper
• ERO1α promotes hypoxic tumour progression and is associated with poor prognosis in pancreatic cancer

  2019cites this paper
• Downregulation of CYB5D2 is associated with breast cancer progression

  2019cites this paper
• Emerging novel mechanisms of action for nitric oxide in cancer progression

  2019cites this paper
• Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism

  2019cites this paper
• Extensive protein S-nitrosylation associated with human pancreatic ductal adenocarcinoma pathogenesis

  2019cites this paper
• Integrated transcriptomic analysis reveals hub genes involved in diagnosis and prognosis of pancreatic cancer

  2019influential citation
• PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer

  2018cites this paper
• Effect of NOS1 regulating ABCG2 expression on proliferation and apoptosis of cervical cancer cells

  2018cites this paper
• Association of endothelial nitric oxide synthase (eNOS) polymorphisms with EGFR-mutated lung adenocarcinoma in Taiwan

  2018cites this paper
• Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma.

  2017cites this paper
• Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma

  2017cites this paper
• Genome-wide screen identifies a novel prognostic signature for breast cancer survival

  2017cites this paper
• Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling

  2017cites this paper
• Regulation of Cell Survival, Apoptosis, and Epithelial-to-Mesenchymal Transition by Nitric Oxide-Dependent Post-Translational Modifications

  2017cites this paper
• NO• and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential

  2017cites this paper
• Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221

  2016cites this paper